New study finds a connection between bacteria in the gut and anti-tumour immune responses in the liver. The bacteria in the gut may affect the liver's anti-tumor immune function, according to the study. The study findings have implications for understanding the mechanisms that lead to liver cancer and pave the way to treat them. The study showed that bacteria found in the gut of mice affect the liver's anti-tumour immune function. "What we found using different tumour models is that if you treat mice with antibiotics and thereby deplete certain bacteria, you can change the composition of immune cells of the liver, affecting tumour growth in the liver," said lead author Tim Greten, from the Center for Cancer Research (CCR) at the National Cancer Institute (NCI), a part of the National Institutes of Health. ‘If you treat mice with antibiotics and thereby deplete certain bacteria, you can change the composition of immune cells of the liver, affecting tumour growth in the liver.’ In humans, the greatest proportion of the body's total microbiome -- the collection of bacteria and other micro-organisms that live in or on the body -- is in the gut. Despite extensive research into the relationship between the gut microbiome and cancer, the role of gut bacteria in the formation of liver cancer has remained poorly understood. For the study, published in the journal Science, the team carried out a series of experiments with mice. They used three mouse liver cancer models, and found that when they depleted gut bacteria using an antibiotic "cocktail," the mice that had the antibiotics developed fewer and smaller liver tumours and had reduced metastasis to the liver. The investigators found that antibiotic treatment increased the numbers of a type of immune cell called NKT cells in the livers of the mice. In all three mouse models, the reduction in liver tumour growth that resulted from antibiotic treatment was dependent on these NKT cells. Further, they found that the accumulation of the NKT cells in the liver resulted from an increase in the expression of a protein called CXCL16 on cells that line the inside of capillaries in the liver. As bile acids can control the expression of CXCL16, the team treated mice with bile acids. They changed the number of NKT cells in the liver, and thus the number of tumours in the liver. Finally, they found that one bacterial species, Clostridium scindens, controlled metabolism of bile acids in the mouse gut and ultimately CXCL16 expression, NKT cell accumulation, and tumour growth in the liver. They found that bile acids also controlled the expression of the CXCL16 protein in the liver of humans, suggesting that the novel mechanism described in the study may potentially apply to cancer patients. Source: IANS << Difference Between Two Neuropsychological Tests for Assessin... Use of Keywords - 'Weight Loss' Has Increased Whereas 'Obesi... >> Recommended Reading New Treatment Option for Liver Cancers New minimally invasive cancer therapy may show promise as a curative treatment option for patients with early-stage liver cancer. READ MORE Novel Protein that can Fight against Liver Cancer Identified A new mechanism discovered can turn off the switch to prevent tumor growth in liver cancer. The protein called LHPP (Phospholysine Phosphohistidine Inorganic Pyrophosphate Phosphatase) prevents the spread of cancer. READ MORE Patient Outcomes from Alcohol-Related Liver Cancer are the Worst Alcohol-related liver cancer patients are more likely to cause death when compared Normal liver cancer, finds a new study. READ MORE Hepatitis C Virus Screening Rates Low Despite Increase in Liver Cancer Rates Hepatitis C virus screening rates remain low in the United States despite the steady increase of liver cancer incidence. READ MORE Current Treatments for Liver Cancer Current Treatments for Liver Cancer (also known as hepatoma or hepatocellular carcinoma) can result in complete cure of the disease if it is detected early. READ MORE Cysts and Tumours Ultrasound scan reveals multiple cysts and there is no function on that kidney when tested on DMSA scan. A vast majority of them resolve spontaneously. READ MORE Fatty Liver Disease: A Growing Health Problem in India Non alcoholic fatty liver disease (NAFLD) is the leading cause of liver dysfunction worldwide and is a rapidly growing health problem in India. READ MORE Hepatitis A Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. Hepatitis A vaccine is available that is 95% effective in preventing the disease. READ MORE Living Donor Liver Transplant: What Are the Risks? The risk of dying as a result of a living donor liver segment removal is between 0.2-2.0%. The risk of morbidity is anywhere between 1.3% (in highly experienced centers) to 60%. READ MORE Milk Thistle Milk Thistle is a resourceful natural plant which has many medicinal benefits. In herbal medication milk thistle is used in cases of liver diseases. READ MORE Probiotics - Support System for the Gut Probiotics are live microorganisms that resemble the “good bacteria” in our gut. Science is yet to fully explore the healing potential of probiotics; meanwhile some studies have ruled in their favor. READ MORE Tumor Markers For Cancer Diagnosis and Prognosis An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive results. READ MORE Wilson's Disease This is a rare inherited systemic disorder of copper metabolism, affecting the liver mainly before other organs. READ MORE Most Popular on Medindia Hearing Loss Calculator Indian Medical Journals Blood Donation - Recipients More News on: Hepatitis ACysts and TumoursLiverTumor Markers For Cancer Diagnosis and PrognosisWilson's DiseaseProbiotics - Support System for the GutMilk ThistleCurrent Treatments for Liver CancerFatty Liver Disease: A Growing Health Problem in IndiaLiving Donor Liver Transplant: What Are the Risks?